Avenue Therapeutics, Inc. (ATXI) Financials
ATXI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.9 million | 1.2 million |
| 2023-09-30 | 502000 | 5.0 million |
| 2023-06-30 | 1.7 million | 7.8 million |
| 2023-03-31 | 8.4 million | 10.6 million |
ATXI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 676000 | 307000 |
| 2023-09-30 | -1.9 million | 561000 |
| 2023-06-30 | -6.7 million | 27000 |
| 2023-03-31 | -1.6 million | 11000 |
ATXI Net Income
No data available :(
ATXI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 1.8 million | - | - |
| 2023-09-30 | 161000 | - | - |
| 2023-06-30 | 1.6 million | - | - |
| 2023-03-31 | 8.2 million | - | - |
ATXI Shares Outstanding
ATXI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 3.0 million | 982000 | 1.1 million | - |
| 2023-09-30 | 1.0 million | 907000 | 1.2 million | - |
| 2023-06-30 | 2.0 million | 3.0 million | 896000 | - |
| 2023-03-31 | - | 5.4 million | 984000 | - |
ATXI Cost of Revenue
No data available :(
ATXI
Price: $6.20
52 week price:
Earnings Per Share: -0.98 USD
P/E Ratio: -0.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 246300
Market Capitalization: 6.6 million